BioStem Technologies, Inc. (BSEM)

BioStem Technologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.64	0.24	0.77	0.34	0.1	0.14
Cash & Cash Equivalents	0.64	0.24	0.77	0.34	0.1	0.14
Cash Growth	332.70%	-68.99%	126.88%	237.97%	-28.45%	-88.03%
Receivables	41.62	11.37	0.04	0.3	0.01	0.08
Inventory	0.88	0.66	0.4	0.26	0.57	0.57
Other Current Assets	0.59	0.33	0.28	0.04	0.17	0.28
Total Current Assets	43.73	12.6	1.49	0.94	0.85	1.07
Property, Plant & Equipment	1.36	1.37	1.37	1.28	1.35	1.58
Long-Term Investments	0	-0.35	0	0	0	0
Goodwill	0.98	0.24	0.24	0.24	0.47	0.47
Intangible Assets	1.45	0.35	0.36	0.21	0	0
Other Long-Term Assets	0.02	0.4	0	0	0	0.04
Total Long-Term Assets	1.94	2.01	1.98	1.73	1.82	2.09
Total Assets	45.67	14.61	3.47	2.67	2.67	3.15
Accounts Payable	2.82	1.39	0.57	0.65	0.61	0.69
Deferred Revenue	0.01	0.01	1.48	2.47	1.88	1.13
Current Debt	4.13	4.49	4.05	3.03	4.12	3.91
Other Current Liabilities	31.84	9.73	0.23	0.4	0.19	0.15
Total Current Liabilities	38.81	15.62	6.33	6.54	6.8	5.89
Long-Term Debt	0.22	0.27	1.04	1.8	1.5	1.2
Other Long-Term Liabilities	0.01	0.07	0.05	0.12	0	0
Total Long-Term Liabilities	0.23	0.33	1.09	1.92	1.5	1.2
Total Liabilities	39.03	15.95	7.42	8.47	8.3	7.09
Total Debt	4.36	4.77	5.09	4.83	5.63	5.11
Debt Growth	-13.10%	-6.19%	5.34%	-14.11%	9.98%	-1.65%
Common Stock	0.02	0.02	0.01	0.01	3.68	3.66
Retained Earnings	-41.18	-45.62	-37.02	-29.95	-28.2	-25.86
Comprehensive Income	0	-0	0	-0	-0.74	-1.38
Shareholders' Equity	6.64	-1.34	-4.08	-5.96	-5.8	-4.09
Total Liabilities and Equity	45.67	14.61	3.47	2.67	2.67	3.15
Net Cash / Debt	-3.72	-4.53	-4.32	-4.49	-5.52	-4.97
Net Cash Per Share	-0.17	-0.33	-0.38	-0.38	-0.60	-0.54
Working Capital	4.93	-3.02	-4.84	-5.6	-5.95	-4.82
Book Value Per Share	0.41	-0.10	-0.36	-0.51	-0.63	-0.44

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.